Dr. David Roblin has been appointed to Xceleron’s board of directors in a non-executive capacity and Dr. Stuart Best has been named senior director of operations. Dr. Roblin joins the company from Pfizer Global R&D, where he most recently served as senior vice president R&D, research head and site director. His experience includes therapeutic areas within the spectrum of small and large molecule R&D. Dr. Best joins the company from Merck, Scotland where he was head of Bioanalysis. D...